Aminophyllin Iv Fresenius
No structure available
This product's active ingredient could not be matched to a single known compound.
Registration
- Applicants
- 1
- Registrations
- 1
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Fresenius Medical Care South Africa (Pty) LtdCertificate held by Fresenius Kabi Manufacturing SA (Pty) Ltd | Aminophyllin iv fresenius | 250 mg | G0628 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Aminophyllin iv fresenius 250 MG EACH 10,0 ml SOLUTION CONTAINS AMINOPHYLLINE A 250,0 mg | 250 mgSolution for injection. | G0628Approved 17 October 2020 | Old Medicine | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.